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ABSTRACT 
The Optimal designs used in a clinical trial depends on the goals of the study. Common 
goals are estimating model parameters and choosing between models. D-optimal designs are used 
when the goal is to estimate the model parameters. This is achieved by maximizing the determinant 
of the information matrix. When the goal is model discrimination, T-optimal designs are used. The 
design is optimal when the minimum difference between the models is maximized. Generally, D-
optimal designs are not efficient when the goal is model discrimination and T-optimal designs 
perform poorly when the goal is parameter estimation. However, because D-optimal and T-optimal 
designs have a common criterion structure, they can be combined into a new design called a DT-
optimal design. DT-optimal designs provide a balance between parameter estimation and model 
discrimination. The efficiency of DT-optimal designs relative to D and T-optimal designs shows 
that they work for parameter estimation and model discrimination. 
 
Keywords: Experimental design; Dose-response; Dual objective optimal design, 
efficiency. 
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CHAPTER 1. INTRODUCTION 
Dose response studies are a common type of clinical trial used to determine the appropriate 
dose of a drug to give to patients. Patients are given a range of dose levels that help explain possible 
reactions to the drug in question.  Nonmonotone dose-response functions are common and three 
types will be considered: strong-downturn, slight-downturn, and no-downturn. The functions will 
be discussed in more detail in Chapter 2.  For drugs that exhibit a downturn in the dose-response, 
a common question among researches is whether this downturn is significant or not.  To assess 
this significance two competing models can be estimated.  One model describing the full dose-
response function with a downturn, and one that only describes the increasing component of the 
function. 
In order to describe these functions, parameters must be estimated.  This is done using an 
experimental design.  Designs consist of design points (dose levels) and weights (subject 
allocations).  In order for the experiment to be efficient, the optimal design must be used.  Because 
there are many different objectives possible when conducting clinical trials, there are also many 
types of optimal designs.  Here we consider T-optimal designs, D-optimal designs, and their 
combination, DT-optimal designs.   
Welshons et al. (2003) gives motivation for studying dose-response functions with a 
downturn and contains useful information on obtaining optimal designs, such as nominal 
parameter values and the dose range.  A Probit model will be used to describe the dose-response 
functions because it can easily describe the downturn by adding a quadratic term and it provides a 
good fit to Welshons’ data, see Hyun (2013).  We use T-optimal designs for discrimination 
between the rival two and three parameter models.  In other words, we can use T-optimal designs 
to choose the most appropriate model.  Atkinson and Fedorov (1975a,b) show that T-optimality 
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criterion maximizes the minimum difference between the two competing models,  which in turn 
gives more power to an F-test of lack of fit, assuming the first model is true.  More information 
about and uses of T-optimal designs can be found in Ucinski and Bogacka (2005), Wiens (2009), 
Tommasi and L´opez-Fidalgo (2010), Atkinson, Bogacka and Bogachi (1998), and Foo and 
Duffull (2011).  D-optimal designs are used when the goal of the study is accurate parameter 
estimation.  Box and Lucas (1959) show that D-optimal designs maximize the determinant of the 
Fisher Information Matrix.  In some sense, this can be thought of as minimizing the variance of 
the parameter estimates.   
There have been many attempts at seeking a balance between model discrimination and 
parameter estimation. Hill et al. (1968) gives motivation for why researches might be interested in 
a single design for both goals.  Instead of having a design for one stage of the experiment where 
the goal is to find a good model, and a completely separate design for the next stage where model 
parameters are to be estimated, they suggest that a design to do both at the same time would allow 
researchers to combine the two stages.  This would save both time and precious resources.  Most 
importantly the overall number of subjects for the study would be decreased. Waterhouse et al. 
(2005) has a practical situation where researchers might actually need to discriminate between 
models and estimate parameters.  They are researching optimal sampling times for subjects with 
cystic fibrosis.  In their study, they need not only to discriminate between two linear and two 
nonlinear models, but also estimate the model parameters in order to determine the optimal 
sampling times.   
DT-optimal designs, introduced by Atkinson (2008) as a way to balance model 
discrimination and parameter estimation, are found by simply maximizing a weighted product of 
T-efficiency and D-efficiency.  This represents relative importance of the two objectives.  More 
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details will be given in Chapter 3.  A design is considered to be an optimal design when it satisfies 
a certain optimality criterion, and it is verified by the General Equivalence Theorem in Kiefer 
(1974).  The paper also has background on equivalency theorems in general if more information 
is desired. 
In Chapter 2, more information about dose-response functions is given, as well as 
background on D-optimal and T-optimal designs. DT-optimal designs and the DT-optimal 
equivalence theorem are discussed in detail in Chapter 3. Efficiency calculations are shown in 
Chapter 4 for D-optimal, T-optimal, and DT-optimal designs. Chapter 5 contains concluding 
remarks as well as potential further research. 
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CHAPTER 2. BACKGROUND 
2.1. Dose-response Studies  
Plotting the logarithm of dose on the X-axis and the drug response on the Y-axis can result 
in a variety of shapes.  Three of those shapes are under consideration here.  The first is called a 
“strong-downturn” function.  This function resembles a concave parabola.  The second is called a 
“slight-downturn” function.  Also resembling a concave parabola, this function is “flatter” than a 
strong-downturn dose-response function.  The third is called a “no-downturn” function and 
resembles a Sigmoid “S” curve.  
 
Figure 2.1. Strong-downturn dose response 
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Figure 2.2. Slight-downturn dose response 
 
Figure 2.3. No-downturn dose response 
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2.2. T-optimal Designs 
In some studies, researches may have a hard time deciding between competing plausible 
models.  In these cases, designs that are efficient at model discrimination are useful because they 
can help select the most appropriate model using the least effort and resources.  Atkinson and 
Fedorov (1975) consider designs for discrimination between two rival regression models 𝜂1(𝑥, 𝛩1) 
and 𝜂2(𝑥, 𝛩2), whose forms are given in Section 4.1.  The model parameters are estimated by least 
squares.  If it is assumed that the first model is true, then  
                   𝑦𝑖𝑗 = 𝜂1(𝑥𝑖, 𝛩1) + 𝜀𝑖𝑗,         𝜀𝑖𝑗 ~ 𝑁(0, 𝜎
2),                                     (2.1) 
where 𝑦𝑖𝑗 is continuous and represents a dose response, 𝑗 =  1, 2, 3, . . . , 𝑛𝑖, 𝑖 =  1, 2, 3, . . . , 𝑘,  𝑛𝑖  
is the number of subjects allocated to 𝑥𝑖, and 𝛩1 = {𝜃11, 𝜃12, … , 𝜃1𝑝}is the vector of model 
parameters.  The values of 𝑥𝑖 are selected for a dose range 𝑋.  Finally, the sample size, 𝑁 =
∑ 𝑛𝑖
𝑘
𝑖=1 .   
Let 𝜉 = {𝑥𝑖, 𝑤𝑖}
𝑘 denote 𝑘 design points (dose levels), where 𝑥𝑖 is the 𝑖
𝑡ℎ log dose and 𝑤𝑖 
is the corresponding weight at 𝑥𝑖.  Here 𝑥𝑖𝜖𝑋 and the nearest positive inter of 𝑁 ∗ 𝑤𝑖 is the number 
of subjects assigned to 𝑥𝑖.  The lack of fit sum of squares for model 𝜂2(𝑥, 𝛩2) is made as large as 
possible by maximizing  
                                         ∆1(𝜉) = ∑ 𝑤𝑖{𝜂1(𝑥𝑖, 𝛩1) − 𝜂2(𝑥𝑖 , ?̂?2)}
2𝑘
𝑖=1 ,     (2.2) 
where 𝛩2̂ are the calculated parameters of 𝜂2  that minimize its distance from 𝜂1 and  ∆1(𝜉) is called 
the objective function of a design 𝜉.  Note that the values of 𝑥𝑖 and 𝑤𝑖 are found using the algorithm 
in Section 3.2.  The values of 𝛩1 come from previous research and can be seen below in Table 4.1.  
The design maximizing (2.2) is called T-optimal design, it is denoted as 𝜉𝑇
∗ . 
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Atkinson and Fedorov (1975) give the Equivalence Theorem for T-optimal designs as the 
following, 
                                                         𝛹1(𝑥, 𝜉𝑇
∗)  ≤  ∆1(𝜉𝑇
∗),                                     (2.3) 
where  
𝛹1(𝑥, 𝜉𝑇
∗) = {𝜂1(𝑥𝑖, 𝛩1) − 𝜂2(𝑥𝑖 , ?̂?2)}
2
. 
Equality in (2.3) holds at the design points of the T-optimal design. 
2.3. D-optimal Designs 
When the goal of the study is parameter estimation, D-optimal designs are most commonly 
used.  As mention earlier, D-optimal designs maximize the determinant of the Fisher Information 
Matrix.  Under (2.1), the Fisher Information matrix can be written as  
                                                            𝑀1(𝜉) = 𝐹1
𝑇𝑊𝐹1,                                                         (2.4) 
 
where 𝑊 = 𝑑𝑖𝑎𝑔{𝑤𝑖} and 
                                    𝐹1(𝑥, 𝛩1) = {
𝛿𝜂1(𝑥1,𝛩1)
𝛿𝛩1
,
𝛿𝜂1(𝑥2,𝛩1)
𝛿𝛩1
, … ,
𝛿𝜂1(𝑥𝑘,𝛩1)
𝛿𝛩1
} 𝑝×𝑘,                       (2.5) 
𝛿𝜂1(𝑥𝑖,𝛩1)
𝛿𝛩1
= {
𝛿𝜂1(𝑥𝑖,𝛩1)
𝛿𝜃11
,
𝛿𝜂1(𝑥𝑖,𝛩1)
𝛿𝜃12
, … ,
𝛿𝜂1(𝑥𝑖,𝛩1)
𝛿𝜃1𝑝
}
𝑇
. 
The D-optimal design 𝜉𝐷
∗  maximizes |𝑀1(𝜉)|.  Kiefer and Wolfowitz (1960) give the equivalence 
theorem for D-optimal designs as  
                                                             𝛹2(𝑥, 𝜉𝐷
∗ ) ≤ 𝑝,                                                            (2.7) 
where 𝑝 is the number of parameters in the first model and 
𝛹2(𝑥, 𝜉𝐷
∗ ) =  𝑓1
𝑇(𝑥)𝑀1
−1(𝜉𝐷
∗ )𝑓1(𝑥), 
𝑓1(𝑥, 𝛩1) =
𝛿𝜂1(𝑥1,𝛩1)
𝛿𝛩1
. 
Similarly to T-optimality, equality in (2.7) holds at the design points of the D-optimal design. 
 
8 
 
CHAPTER 3. DT-OPTIMAL DESIGNS 
3.1. DT-optimality 
 The DT-optimal optimality criterion is a weighted product of the efficiencies of T-optimal 
and D-optimal designs.  The DT-optimal design maximizes the efficiencies for model 
discrimination (T-optimal design) and parameter estimation (D-optimal design).  According to 
Atkinson (2008), the efficiency of any design 𝜉 relative to the T-optimal design 𝜉𝑇
∗  is called T-
efficiency: 
                                                            𝐸𝑇 = ∆1(𝜉)/∆1(𝜉𝑇
∗).                                                  (3.1) 
In other words, it is the ratio of the objective function for the design in question to the optimal 
design.  D-efficiency is  
                                                   𝐸𝐷 = {|𝑀1(𝜉)|/|𝑀1(𝜉𝐷
∗ )|}(1/𝑝).                                         (3.2) 
If we denote the efficiency of a design 𝜉 as 𝐸(𝜉), we can calculate how many more subjects 
a researcher would need to have the same accuracy as the optimal design using the formula 
                                                      𝜋 = 100 × (
1
𝐸(𝜉)
− 1)%.                                                (3.3) 
For example, 𝐸(𝜉) = 0.5 implies a study would 100% or twice as many subjects to be just as 
accurate as the optimal design. 
To find a DT-optimal design we maximize the weighted product of (3.1) and (3.2).              
{𝐸𝑓
𝑇}
(1−𝜆)
{𝐸𝑓
𝐷}
𝜆
= {∆1(𝜉)/∆1(𝜉𝑇
∗)}(1−𝜆){|𝑀1(𝜉)|/|𝑀1(𝜉𝐷
∗ )|}𝜆/𝑝,     (0 ≤ 𝜆 ≤ 1).                 (3.4) 
If 𝜆 = 0 (3.4) becomes T-efficiency and if 𝜆 = 1 (3.4) becomes D-efficiency.  We can simplify 
(3.4) by first taking the log, 
(1 − 𝜆)𝑙𝑜𝑔∆1(𝜉) + (𝜆/𝑝)𝑙𝑜𝑔|𝑀1(𝜉)| − (1 − 𝜆)𝑙𝑜𝑔∆1(𝜉𝑇
∗) − (𝜆/𝑝)𝑙𝑜𝑔|𝑀1(𝜉𝐷
∗ )|            (3.5) 
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then removing the terms involving the optimal designs 𝜉𝐷
∗  and 𝜉𝑇
∗  because they are constant when 
we maximize (3.4) over 𝜉, to find 
                                     𝛷1
𝐷𝑇(𝜉) = (1 − 𝜆)𝑙𝑜𝑔∆1(𝜉) + (𝜆/𝑝)𝑙𝑜𝑔|𝑀1(𝜉)|.                       (3.6) 
The design maximizing (3.5) is called DT-optimal and is denoted 𝜉𝐷𝑇
∗ .  Here 𝜆 is the relative 
importance of the D-optimality criterion compared to the T-optimality criterion.  When 𝜆 = 1 the 
design maximizing (3.5) is the D-optimal design, and when 𝜆 = 0 the design maximizing (3.5) is 
the T-optimal design. 
 The equivalence theorem for DT-optimality design (Atkinson 2008) states that  
                                                         𝛹𝐷𝑇(𝑥, 𝜉𝐷𝑇
∗ ) ≤ 1,                                                      (3.7) 
where  
𝛹𝐷𝑇(𝑥, 𝜉𝐷𝑇
∗ ) = (1 − 𝜆)𝛹1(𝑥, 𝜉𝐷𝑇
∗ )/∆1(𝜉𝐷𝑇
∗ ) + (𝜆/𝑝)𝛹2(𝑥, 𝜉𝐷𝑇
∗ )   
           = (1 − 𝜆){𝜂1(𝑥𝑖, 𝛩1) − 𝜂2(𝑥𝑖, ?̂?2)}
2
/∆1(𝜉𝐷𝑇
∗ ) + (𝜆/𝑝)𝑓1
𝑇(𝑥)𝑀1
−1(𝜉𝐷𝑇
∗ )𝑓1(𝑥). 
Similarly to both the T-optimal and D-optimal equivalence theorems equality in (3.6) holds at the 
design points of the DT-optimal design. 
3.2. Algorithm to Find Optimal Design 
 We can find the DT-optimal design numerically using the well-known V-algorithm 
(Fedorov 1972). 
Step 0: Set an initial design 𝜉0 with design points 𝑥1,0, 𝑥2,0, … , 𝑥𝑘,0 and uniform weights 
𝑤1,0, 𝑤2,0, … , 𝑤𝑘,0 = 1/𝑘 
Step 1: Obtain ?̂?2,𝑠: 
                         ?̂?2,𝑠 = arg min
𝛩2,𝑠∈𝛩𝑆
∑ 𝑤𝑖,𝑠 (𝜂1(𝑥𝑖,𝑠, 𝛩1,𝑠) − 𝜂2(𝑥𝑖,𝑠, ?̂?2,𝑠))
2
𝑘
𝑖=1 .                     
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Step 2: Find the design point 
𝑥𝑠
∗ = argmax
𝑥𝑠
∗∈𝑋
(1 − 𝜆)𝑙𝑜𝑔∑ 𝑤𝑖,𝑠 (𝜂1(𝑥𝑖,𝑠, 𝛩1,𝑠) − 𝜂2(𝑥𝑖,𝑠, ?̂?2,𝑠))
2
𝑘
𝑖=1     
+(𝜆/𝑝)𝑙𝑜𝑔|𝑓1
𝑇(𝑥𝑖,𝑠)𝑀1
−1(𝜉𝑠)𝑓1(𝑥𝑖,𝑠)|. 
Step 3: Stop the algorithm if |𝛹𝐷𝑇(𝑥𝑠
∗, 𝜉𝐷𝑇
∗ ) − 1| ≤ 𝜀, 10−8 ≤ 𝜀 ≤ 10−3.  When the algorithm 
stops 𝜉𝑠 is the DT-optimal design. 
Step 4: Otherwise, update the design  
𝜉𝑠+1 = (1 −
1
𝑠+1
) ∗ 𝜉𝑠 + 𝜉𝑛𝑒𝑤, 
 𝜉𝑛𝑒𝑤 = {
𝑥𝑠
∗
1
𝑠+1
}. 
Step 5: Set 𝑠 = 𝑠 + 1 and repeat Steps 1 – 5.  
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CHAPTER 4. DESIGN RESULTS 
4.1. Competing Models 
Two probit models are considered.  The first has three parameters and includes a quadratic 
term.  The second model only has two parameters and does not include a quadratic term.  The two 
models are  
                                          𝜂1(𝑥, 𝛩1) =  𝛷(−(𝜃11 + 𝜃12𝑥𝑖 + 𝜃13𝑥𝑖
2)),                                    (4.1) 
                                                 𝜂2(𝑥, 𝛩2) =  𝛷(−(𝜃21 + 𝜃22𝑥𝑖)).                                            (4.2) 
𝛷 is the cumulative standard normal distribution.  The Fisher Information matrix for 𝜂1(𝑥, 𝛩1) is  
[
 
 
 
 
 
 
 
 
∑𝑤𝑖
𝑘
𝑖=1
𝑒(−(𝜃11+𝑥𝑖𝜃12+𝑥𝑖
2𝜃12)
2
) ∑𝑥𝑖𝑤𝑖
𝑘
𝑖=1
𝑒(−(𝜃11+𝑥𝑖𝜃12+𝑥𝑖
2𝜃12)
2
) ∑𝑥𝑖
2𝑤𝑖
𝑘
𝑖=1
𝑒(−(𝜃11+𝑥𝑖𝜃12+𝑥𝑖
2𝜃12)
2
)
∑𝑥𝑖𝑤𝑖
𝑘
𝑖=1
𝑒(−(𝜃11+𝑥𝑖𝜃12+𝑥𝑖
2𝜃12)
2
) ∑𝑥𝑖
2𝑤𝑖
𝑘
𝑖=1
𝑒(−(𝜃11+𝑥𝑖𝜃12+𝑥𝑖
2𝜃12)
2
) ∑𝑥𝑖
3𝑤𝑖
𝑘
𝑖=1
𝑒(−(𝜃11+𝑥𝑖𝜃12+𝑥𝑖
2𝜃12)
2
)
∑𝑥𝑖
2𝑤𝑖
𝑘
𝑖=1
𝑒(−(𝜃11+𝑥𝑖𝜃12+𝑥𝑖
2𝜃12)
2
) ∑𝑥𝑖
3𝑤𝑖
𝑘
𝑖=1
𝑒(−(𝜃11+𝑥𝑖𝜃12+𝑥𝑖
2𝜃12)
2
) ∑𝑥𝑖
4𝑤𝑖
𝑘
𝑖=1
𝑒(−(𝜃11+𝑥𝑖𝜃12+𝑥𝑖
2𝜃12)
2
)
]
 
 
 
 
 
 
 
 
 
                (4.3) 
4.2. Nominal Parameter Values and Dose Range 
In order to illustrate the 3 types of response functions, three sets of nominal parameter 
values and the log dose range were adopted from Ming (2014).  Estimates for the two parameter 
model provide a minimum distance from 𝜂1(𝑥, 𝛩1).  They are the values last used to find the 
minimum distance when the algorithm detailed above stops.  Welshons et al. (2003) gives 
motivation for using the design space [−14, −4] and the initial parameter values for the probit 
model for the strong-downturn dose response function.  
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Table 4.1. Parameter sets for 𝜂1 and estimates for 𝜂2 
 𝜃11 𝜃12 𝜃13 𝜃21 𝜃22 
Strong-downturn 4.630 1.230 0.070 0.03125 -0.0125 
Slight-downturn 0.175 0.277 0.024 -1.453125 -0.1515625 
No-downturn -6.690 -0.600 0.010 -5.734375 -0.5984375 
 
The following plots show the two competing models for each dose-response function.  
 
Figure 4.1. The two competing models for the strong-downturn dose response 
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Figure 4.2. The two competing models for the slight-downturn dose response 
 
Figure 4.3. The two competing models for the no-downturn dose response 
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4.3. T-optimal designs 
 Recall T-optimal designs maximizing the minimum difference between the competing 
models.  The T-optimal designs are: 
For the Strong-downturn dose response function 
                                                      𝜉𝑇
∗ = {
−14 −9 −4
0.25 0.50 0.25
},                                                 (4.4) 
For the Slight-downturn dose response function 
                                                     𝜉𝑇
∗ = {
−14 −9.2 −4
0.27 0.43 0.30
},                                                 (4.5) 
For the No-downturn dose response function 
                                                     𝜉𝑇
∗ = {
−11.1 −8.2
0.43 0.57
},                                                          (4.6) 
Consider a drug with a strong-downturn dose response.  In this scenario we would assign 
25% of the subjects to each log dose boundary and 50% of the subjects to the log dose level -9.  
This would allow us to most accurately maximize the distance between the two models.  Also 
notice the similarity between (4.4) and (4.5).  The design points are essentially identical, and the 
subjects for the slight-downturn dose response are just a little more evenly distributed with 
different weights.  The T-optimal design for the no-downturn dose response is substantially 
different.  There are only two design points.  This will be a problem when trying to estimate model 
parameters because we need at least as many design points as there are model parameters in order 
to find estimates.  The magnitude of the problem will be quantified when we calculate this design’s 
D-efficiency.   
4.4. D-optimal designs 
Recall D-optimal designs maximizing the determinant of the Fisher Information matrix.  
The D-optimal designs are: 
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For the Strong-downturn dose response function 
                                                𝜉𝐷
∗ = {
−13.2 −10.3 −7.2
0.32 0.17 0.18
    
−4.3
0.33
},                                     (4.7) 
For the Slight-downturn dose response function 
                                                    𝜉𝐷
∗ = {
−13 −9.5 −4
0.33 0.34 0.33
},                                                   (4.8) 
For the No-downturn dose response function 
                                                    𝜉𝐷
∗ = {
−11.1 −9.6 −8
0.34 0.33 0.33
},                                                (4.9) 
 All three dose response functions have unique D-optimal designs.  There are still 
similarities however.  In (4.7) there are four design point while in (4.8) there are only three. 
However notice that the boundaries are similar and that (4.7)’s middle two design points are 
basically a split in both log dose and weight of the middle design point of (4.8).  It is also worth 
noticing that both (4.8) and (4.9) have essentially uniform weights.  This is a typical trait of D-
optimal designs when the number of model parameters is equal to the number of design points.  
To understand how to use a D-optimal design consider (4.9).  If our drug exhibits a no-downturn 
dose response we would allocate and equal amount of subjects to the log dose levels -11.1, -9.6, 
and -8.  This would allow researchers to most accurately estimate the models parameters. 
4.5. DT-optimal designs 
Recall DT-optimal designs maximizing the weighted product of D-efficiency and T-
efficiency.  The DT-optimal designs are: 
For the Strong-downturn dose response function 
                                                    𝜉𝐷𝑇
∗ = {
−13.9 −9 −4
0.28 0.45 0.27
},                                             (4.10) 
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Figure 4.4. Optimality check for parameter set 1 
For the Slight-downturn dose response function 
                                                     𝜉𝐷𝑇
∗ = {
−14 −9.3 −4
0.30 0.40 0.30
},                                              (4.11) 
 
Figure 4.5. Optimality check for parameter set 2 
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For the No-downturn dose response function 
                                                   𝜉𝐷𝑇
∗ = {
−11.1 −9.5 −8.1
0.41 0.18 0.41
},                                            (4.12) 
 
Figure 4.6. Optimality check for parameter set 3 
 This time consider a drug with a slight-downturn dose response.  (4.11) tells us that 
approximately 30% of the subjects should go to the boundary log dose values, and that 40% of the 
subjects should be given a log dose value of -9.3.  With this we could provide a good balance 
between model discrimination and parameter estimation.  The figure following each designs is a 
visual way to check if the design is really optimal.  According to (3.7), at the design points of the 
DT-optimal design, 𝛹𝐷𝑇(𝑥, 𝜉𝐷𝑇
∗ ) = 1.  Sticking with the slight downturn dose response example, 
we can see that this is the case.  𝛹𝐷𝑇(𝑥, 𝜉𝐷𝑇
∗ ) = 1 at 𝑥 = −14,−9.3, 𝑎𝑛𝑑 − 4.  It is also worth 
noting that the DT-optimal designs for strong-downturn and slight-downturn dose response 
functions are very similar to the T-optimal designs.  However for a no-downturn dose response 
function the DT-optimal design is more similar to the D-optimal design.   
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CHAPTER 5. EFFICIENCY 
Efficiency is used to compare a given design to the optimal design.  Recall (3.1) and (3.2) 
for calculating T-efficiency and D-efficiency.  Using these we can calculate the efficiency of the 
DT-optimal design relative to the T-optimal and D-optimal designs for each parameter set.   
For the strong-downturn dose-response function:  
Table 5.1. Efficiency for parameter set 1 
 𝐸𝑇(𝜉) 𝐸𝐷(𝜉) 
𝜉𝑇
∗  1.00 0.79 
𝜉𝐷
∗  0.50 1.00 
𝜉𝐷𝑇
∗  0.95 0.85 
 
 Here we can see that the T-optimal design is only about 80% efficient at parameter 
estimation.  This means the about 25% more subjects would be required to reach the same accuracy 
as the D-optimal designs, according to (3.3).  However the D-optimal design preforms even worse 
at model discrimination.  As stated before, an efficiency of 50% means that twice as many subjects 
would be needed to be as accurate as the T-optimal design.  The DT-optimal design preforms much 
better in both cases.  With a T-efficiency of 95% only about 6% more subjects would be needed 
to reach the same accuracy as the T-optimal design.  Also a D-efficiency of 85% means about 18% 
more subjects would be required to be just as accurate as the D-optimal design at parameter 
estimation.     
 
 
 
19 
 
Table 5.2. Efficiency for parameter set 2 
 𝐸𝑇(𝜉) 𝐸𝐷(𝜉) 
𝜉𝑇
∗  1.00 0.97 
𝜉𝐷
∗  0.85 1.00 
𝜉𝐷𝑇
∗  0.98 0.98 
 
 For the slight-downturn dose response we can see that all three optimal designs are fairly 
efficient.  Looking back at (4.5), (4.8), and (4.11), we can see that all three designs are pretty 
similar, so the high efficiencies aren’t surprising. However DT-optimal designs are still slightly 
better if both parameter estimation and model discrimination are important. 
Table 5.3. Efficiency for parameter set 3 
 𝐸𝑇(𝜉) 𝐸𝐷(𝜉) 
𝜉𝑇
∗  1.00 0.14 
𝜉𝐷
∗  0.65 1.00 
𝜉𝐷𝑇
∗  0.83 0.92 
 
 When we consider the no-downturn dose response function T-optimal designs are very 
inefficient at parameter estimation.  At 14% D-efficiency, about 615% more subjects would be 
needed to accurately estimate model parameters.  The reason this design is so bad at parameter 
estimation is because there are only two design points, while the model has three parameters.  The 
T-efficiency of the D-optimal design is 65%.  About 54% more subjects would be needed to be as 
accurate at model discrimination as the T-optimal design.  The DT-optimal design has a T-
efficiency of 83% and a D-efficiency of 92%.  21% and 9% more subjects would be needed to 
reach the same accuracy as the T-optimal and D-optimal designs, respectively.    
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CHAPTER 6. CONCLUSIONS 
 The DT-optimal design for the strong-downturn dose response function was very similar 
to the T-optimal design.  For the slight-downturn dose response function all three designs were 
similar, only the weights for the D-optimal design were different.  The DT-optimal and D-optimal 
designs were nearly the same for the no-downturn dose response. Overall DT-optimal designs 
perform well for both model discrimination and parameter estimation for all three dose response 
functions.  For the strong-downturn and no-downturn dose-response functions D-optimality 
performs poorly when the objective is model discrimination and T-optimality performs poorly for 
parameter estimation, as expected.   
 Despite some similarities in the designs, it is best to use the DT-optimal design in all cases 
if the study has goals to choose a model and estimate parameters.  DT-optimal designs will always 
be at least slightly more efficient at model discrimination than D-optimal designs, and more 
efficient at parameter estimation than T-optimal designs.    
 Future research in this area could include studying DT-optimal designs for different values 
of 𝜆 to see the relationship between 𝜆 and the efficiencies.  Also, because the DT-optimal design 
relies on the nominal parameter values, studying how DT-optimal designs change when the 
parameter values are specified incorrectly would be an interesting research question.  Finally 
another extension could be simulating actual data to use with these designs.  This would allow a 
better picture of how well DT-optimal designs preform at both tasks. 
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APPENDIX. R CODE 
#Estimated Model 2 parameters' range: 
#theta1 [-10,0] 
#theta2 [-0.01, -1] 
#True model with Theta1: 
#theta1 = 4.63 theta1 = 0.175 theta1 = -6.69 
#theta2 = 1.23 theta2 = 0.277 theta2 = -0.60 
#theta3 = 0.07 theta3 = 0.024 theta3 = 0.01 
#Initial value# 
x0 = c(-14, -10, -6, -4) 
n0 = length(x0) 
w = rep(1/n0, n0) 
(D = rbind(x0, w)) 
p = 1 
n = 1 
#define M 
#number of parameter 
k=3 
#value of parameter (change to one of sets above; also change values in the 
loop) 
alpha=-6.69 
beta=-.6 
gamma=.01 
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#define function 
f<-function(x) 
{matrix(c(exp((-1/2)*(gamma*(x^2)+beta*x+alpha)^2), 
          x*exp((-1/2)*(gamma*(x^2)+beta*x+alpha)^2), 
          (x^2)*exp((-
1/2)*(gamma*(x^2)+beta*x+alpha)^2)),nrow=3,ncol=1,byrow=F)} 
 
# define information matrix 
A1<-rep(0,n0) 
A2<-rep(0,n0) 
A3<-rep(0,n0) 
A4<-rep(0,n0) 
A5<-rep(0,n0) 
 
for (i in 1:n0) 
{ 
  A1[i]=w[i]*exp((-1)*(gamma*(x0[i]^2)+beta*x0[i]+alpha)^2) 
  A2[i]=x0[i]*A1[i] 
  A3[i]=x0[i]^2*A1[i] 
  A4[i]=x0[i]^3*A1[i] 
  A5[i]=x0[i]^4*A1[i] 
} 
M0=matrix(c(sum(A1),sum(A2),sum(A3),sum(A2),sum(A3), 
            sum(A4),sum(A3),sum(A4),sum(A5)),nrow=3,ncol=3,byrow=F) 
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while(p > .0001){ 
  Rt1 = c(-5, 5) 
  Rt2 = c(-1, 1) 
  s = c(1, .1) 
  while(max(s) > .01){ 
    theta1 = seq(Rt1[1], Rt1[2], s[1]) 
    theta2 = seq(Rt2[1], Rt2[2], s[2]) 
    eta1 = function(x) 
      {pnorm(-(-6.69 - .6*x + 0.01*x^2))} 
    mod2 = expand.grid(theta1, theta2) 
    diff = rep(NA, nrow(mod2)) 
    for (i in 1:nrow(mod2)){ 
      diff[i] = sum(w*(sapply(x0, eta1) - pnorm(-(mod2[i,1] 
                                                  + mod2[i,2]*x0)))^2) 
    } 
    (theta1hat = mod2[which.min(diff),1]); (theta2hat = mod2[ 
      which.min(diff),2]) 
    s = s/2 
    Rt1[1] = theta1hat - s[1] 
    Rt1[2] = theta1hat + s[1] 
    Rt2[1] = theta2hat - s[2] 
    Rt2[2] = theta2hat + s[2] 
  } 
  theta1hat 
  theta2hat 
  x = seq(-14, -4, .1) 
  a = rep(NA, length(x)) 
  diff2 = rep(NA, length(x)) 
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  for (j in 1:length(x)){ 
    diff2[j] = (.5/(sum(w*(sapply(x0, eta1) - pnorm(-(theta1hat + 
theta2hat*x0)))^2)))* 
               (sapply(x[j], eta1) - pnorm(-(theta1hat + theta2hat *x[j])))^2 
+  
               (.5/3)*(t(f(x[j]))%*%solve(M0)%*%f(x[j])) 
  } 
  (anew = x[which.max(diff2)]) 
  p = abs(max(diff2)-1) 
   
  x0 = c(x0,anew) 
  alpha2 = 1/(n + 1) 
  w = c((1 - alpha2) * w, alpha2) 
  n = n + 1 
  n0 = length(x0) 
  A1<-rep(0,n0) 
  A2<-rep(0,n0) 
  A3<-rep(0,n0) 
  A4<-rep(0,n0) 
  A5<-rep(0,n0) 
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  for (i in 1:n0) 
  { 
    A1[i]=w[i]*exp((-1)*(gamma*(x0[i]^2)+beta*x0[i]+alpha)^2) 
    A2[i]=x0[i]*A1[i] 
    A3[i]=x0[i]^2*A1[i] 
    A4[i]=x0[i]^3*A1[i] 
    A5[i]=x0[i]^4*A1[i] 
  } 
  M0=matrix(c(sum(A1),sum(A2),sum(A3),sum(A2),sum(A3), 
              sum(A4),sum(A3),sum(A4),sum(A5)),nrow=3,ncol=3,byrow=F) 
  print(p) 
  D = rbind(x0,w) 
} 
#Summarize the result 
DT_optimal = by(D[2,], D[1,], FUN = sum) 
DT_optimal 
#plot the two models 
theta1hat 
theta2hat 
y = pnorm(-(theta1hat + theta2hat*x)) 
y1 = eta1(x) 
plot(x, y, cex = 0.3, ylim = c(0, 1), col = "blue", 
     type="l",pch=1) 
lines(x, y1,type="l",pch=1) 
cont.txt=c(expression(eta1), 
           expression(eta2)) 
legend("bottomright", legend=cont.txt, 
       col=c(1,4), lwd=1, lty=c(1,1)) 
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#Verify DT-optimal 
X = D[1,] 
W = D[2,] 
x = seq(-14, -4, .1) 
ds = rep(0,length(x)) 
for (i in 1:length(x)) 
{ds[i] = (.5/(sum(w*(sapply(x0, eta1) - pnorm(-(theta1hat + 
theta2hat*x0)))^2)))* 
         (sapply(x[i], eta1) - pnorm(-(theta1hat + theta2hat *x[i])))^2 +  
         (.5/3)*(t(f(x[i]))%*%solve(M0)%*%f(x[i]))} 
 
cont.txt2 = (expression(psi)) 
plot(x, ds, cex = 0.3, type = "l", pch=1, ylab = cont.txt2, 
     ylim = c(-0.09400517,1)) 
abline(h = 1,pch =1, lty = 3) 
abline(v = c(-11.1, -9.5, -8.1), pch =1, lty = 3) 
 
 
#Calculating Efficiency 
#Obj function: 
sum(w*(sapply(x0, eta1) - pnorm(-(theta1hat + theta2hat*x0)))^2) 
 
#DetM0 
det(M0) 
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######### 
#THETA-1# 
######### 
# T-optimal 
# x0 = c(-14, -9, -4) 
# w = c(0.25, 0.50, 0.25) 
# Obj = 0.09395754 
# DetM0 = 151.6461 
 
# DT-optimal 
# x0 = c(-13.9, -9, -4) 
# w = c(0.28, 0.45, 0.27) 
# Obj = 0.08957937 
# DetM0 = 189.0502 
# theta1hat = 0.03125 
# theta2hat = -0.0125 
 
# D-optimal 
# x0 = c(-13.2, -10.3, -7.2, -4.3) 
# w = c(0.32, 0.17, 18, 0.33) 
# Obj = 0.04710415 
# DetM0 = 2.210567e-07 
 
(Eff.DT.T =  0.08957937/0.09395754) # 0.9534027 
(Eff.DT.D = (189.0502/308.7837)^(1/3)) # 0.8491301 
(Eff.T.D = (151.6461/308.7837)^(1/3)) # 0.7889672 
(Eff.D.T = 0.04710415/0.09395754) # 0.5013344 
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######### 
#THETA-2# 
######### 
# T-optimal 
# x0 = c(-14, -9.2, -4) 
# w = c(0.27, 0.43, 0.30) 
# Obj = 0.01029732 
# DetM0 = 524.7601 
 
# DT-optimal 
# x0 = c(-14, -9.3, -4) 
# w = c(0.30, 0.40, 0.30) 
# Obj = 0.01007072 
# DetM0 = 543.74 
# theta1hat = -1.453125 
# theta2hat = -0.1515625 
 
# D-optimal 
# x0 = c(-13.7, -9.5, -4) 
# w = c(0.33, 0.33, 0.33) 
# Obj = 0.008726613 
# DetM0 = 577.8466 
 
(Eff.DT.T =  0.01007072/0.01029732) # 0.9779943 
(Eff.DT.D = (543.74/577.8466)^(1/3)) # 0.9799252 
(Eff.T.D = (524.7601/577.8466)^(1/3)) # 0.968388 
(Eff.D.T = 0.008726613/0.01029732) # 0.8474645 
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######### 
#THETA-3# 
######### 
# T-optimal 
# x0 = c(-11.1, -8.2) 
# w = c(0.43, 0.57) 
# Obj = 0.004559819 
# DetM0 = 0.0002780678 
 
# DT-optimal 
# x0 = c(-11.1, -9.5, -8.1) 
# w = c(0.41, 0.18, 0.41) 
# Obj = 0.003777845 
# DetM0 = 0.07830435 
# theta1hat = -5.734375 
# theta2hat = -0.5984375 
 
# D-optimal 
# x0 = c(-11.1, -9.6, -8) 
# w = c(0.34, 0.33, 0.33) 
# Obj = 0.002985904 
# DetM0 = 0.1005924 
 
(Eff.DT.T =  0.003777845/0.004559819) # 0.8285077 
(Eff.DT.D = (0.07830435/0.1005924)^(1/3)) # 0.9198992 
(Eff.T.D = (0.0002780678/0.1005924)^(1/3)) # 0.1403444 
(Eff.D.T = 0.002985904/0.004559819) # 0.6548295 
